From Naysayer to Partner: How User Expectations and Needs Are Changing IT’s Role

Steven Goriah, VP of IT, CIO & CISO, Westchester Medical Center During the early weeks of the Covid-19 pandemic, there was a lot of focus on digital health, and the potential it had to improve patient care while increasing efficiency. But as leaders take a stock of how their teams responded — and how it… Read More »

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma

Print this page London UK 9 September 2020 — GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to… Read More »

Perimenopausal Depression in Women with More Variable Levels of Estradiol and Lower Progesterone Levels

Women are at increased risk for depressive symptoms during the menopause transition.  It has long been suspected that falling estrogen levels play a role in triggering the onset of depression; however, if all women experience declining levels of estrogen and progesterone during this transition, why is it that only some women suffer from depression in… Read More »

Moderna CEO expects to know by November whether coronavirus vaccine works: report

Moderna reached human testing for its COVID-19 vaccine candidate in record time, and now with its phase 3 trial moving right along, the company is expecting efficacy data in November—likely after Pfizer and BioNTech, but before everyone else. The biotech believes it’ll know in November whether the vaccine works, CEO Stéphane Bancel said on CNBC Thursday. A readout in October is possible but… Read More »